↓ Skip to main content

American Association for Cancer Research

Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistancem6A Targets in Prostate Cancer: Low METTL3 Induces Therapy Resistance

Overview of attention for article published in Molecular Cancer Research, June 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter
18 X users

Citations

dimensions_citation
23 Dimensions

Readers on

mendeley
14 Mendeley
Title
Mapping of m6A and Its Regulatory Targets in Prostate Cancer Reveals a METTL3-Low Induction of Therapy Resistancem6A Targets in Prostate Cancer: Low METTL3 Induces Therapy Resistance
Published in
Molecular Cancer Research, June 2021
DOI 10.1158/1541-7786.mcr-21-0014
Pubmed ID
Authors

Kellie A. Cotter, John Gallon, Nadine Uebersax, Philip Rubin, Kate D. Meyer, Salvatore Piscuoglio, Samie R. Jaffrey, Mark A. Rubin

X Demographics

X Demographics

The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 14 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 29%
Other 2 14%
Researcher 2 14%
Professor 1 7%
Student > Bachelor 1 7%
Other 0 0%
Unknown 4 29%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 3 21%
Agricultural and Biological Sciences 1 7%
Computer Science 1 7%
Medicine and Dentistry 1 7%
Neuroscience 1 7%
Other 1 7%
Unknown 6 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 August 2022.
All research outputs
#3,418,834
of 24,004,724 outputs
Outputs from Molecular Cancer Research
#193
of 1,952 outputs
Outputs of similar age
#83,365
of 435,409 outputs
Outputs of similar age from Molecular Cancer Research
#5
of 31 outputs
Altmetric has tracked 24,004,724 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,952 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 435,409 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.